The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1509980
The Impact of CD3 ITAM Multiplicity and Sequence on CAR T-Cell Survival and Function
Provisionally accepted- 1 The University of Utah, Salt Lake City, United States
- 2 Baylor College of Medicine, Houston, Texas, United States
Chimeric antigen receptor (CAR) expressing T-cells have shown great promise for the future of cancer immunotherapy with the recent clinical successes achieved in treating different hematologic cancers. Despite these early successes, several challenges remain in the field that require to be solved for the therapy to be more efficacious. One such challenge is the lack of long-term persistence of CD28 based CAR T-cells in patients. Although, CD28 based CAR T-cells elicit a robust acute anti-tumor response, they are more prone to early exhaustion, terminal differentiation and cell death due to their strong signaling patterns. Hence attenuation of signaling strength in CD28 based CARs is an accepted strategy to improve long-term CAR T-cell function and persistence in patients. Previous studies with the conventional T-cell receptor (TCR) have suggested that manipulation of CD3 immunoreceptor tyrosine-based activation motif (ITAM) sequences can alter TCR signaling strength. Based on these studies, we have designed 2 nd generation murine anti-CD19 CD28 based CARs with restricted CD3 ITAM diversity of sequences while maintaining a multiplicity of three. They are called AAA, BBB and CCC based on which CD3 ITAM they express. The goal of the study is to understand the nonredundant signaling properties of the individual CD3 ITAMs and their effect on CAR T-cell function. We hypothesize that the individual CD3ζ ITAMs will exhibit unique signaling properties in the restricted CARs which may allow for optimization of CAR signaling and improve CAR T-cell persistence and function. Testing each of these constructs, we observed that AAA CARs had stronger signaling strength compared to BBB and CCC CARs. The signaling differences were reflected in their functional activation profiles with T-cells expressing ζCCC CARs exhibiting less exhaustion and differentiation.
Keywords: chimeric antigen receptor (CAR), CD3, immunoreceptor tyrosine-based activation motif (ITAM), signaling, Cytokines
Received: 11 Oct 2024; Accepted: 23 Dec 2024.
Copyright: © 2024 Majumdar, Echelibe, Bettini and Bettini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Matthew L Bettini, The University of Utah, Salt Lake City, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.